Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism

por Turpie, Alexander G.G.
Publicado 2012

Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients

por Kwong, Louis, Turpie, Alexander G.G.
Publicado 2015

Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment

por Turpie, Alexander G.G., Purdham, Daniel, Ciaccia, Antonio
Publicado 2017

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

por Kreutz, Reinhold, Haas, Sylvia, Holberg, Gerlind, Lassen, Michael R., Mantovani, Lorenzo G., Schmidt, André, Turpie, Alexander G. G.
Publicado 2016

Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study

por Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Bach, Miriam, Kirchhof, Paulus, Kuhls, Silvia, Lambelet, Marc, Turpie, Alexander G.G.
Publicado 2020

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

por Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Hess, Susanne, Kirchhof, Paulus, Kuhls, Silvia, van Eickels, Martin, Turpie, Alexander G.G.
Publicado 2016

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

por Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Publicado 2020

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA

por Ageno, Walter, Mantovani, Lorenzo G., Haas, Sylvia, Kreutz, Reinhold, Monje, Danja, Schneider, Jonas, Bugge, Jörg-Peter, Gebel, Martin, Turpie, Alexander G. G.
Publicado 2019

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

por Ageno, Walter, Mantovani, Lorenzo G., Haas, Sylvia, Kreutz, Reinhold, Monje, Danja, Schneider, Jonas, van Eickels, Martin, Gebel, Martin, Turpie, Alexander G. G.
Publicado 2017

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa a...

por Martínez, Carlos Arturo Areán, Lanas, Fernando, Radaideh, Ghazi, Kharabsheh, Suleiman M., Lambelet, Marc, Viaud, Marco Antonio Lavagnino, Ziadeh, Naser Samih, Turpie, Alexander G.G.
Publicado 2018

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

por Beyer-Westendorf, Jan, Camm, A. John, Fox, Keith A. A., Le Heuzey, Jean-Yves, Haas, Sylvia, Turpie, Alexander G. G., Virdone, Saverio, Kakkar, Ajay K.
Publicado 2019

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies

por Haas, Sylvia, Mantovani, Lorenzo G., Kreutz, Reinhold, Monje, Danja, Schneider, Jonas, Zell, Elizabeth R., Tamm, Miriam, Gebel, Martin, Bugge, Jörg‐Peter, Ageno, Walter, Turpie, Alexander G. G.
Publicado 2021

Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA stud...

por Klok, Frederikus A., Barco, Stefano, Turpie, Alexander G. G., Haas, Sylvia, Kreutz, Reinhold, Mantovani, Lorenzo G., Gebel, Martin, Herpers, Matthias, Bugge, Joerg‐Peter, Kostantinides, Stavros V., Ageno, Walter
Publicado 2018

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis

por Cano, Stefan, Mantovani, Lorenzo, Folkerts, Kerstin, Gebel, Martin, Sahin, Kurtulus, Zell, Elizabeth, Monje, Danja, Schneider, Jonas, Eickels, Martin van, Haas, Sylvia, Kreutz, Reinhold, Ageno, Walter, Turpie, Alexander G. G.
Publicado 2018

Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease

por Goto, Shinya, Haas, Sylvia, Ageno, Walter, Goldhaber, Samuel Z., Turpie, Alexander G. G., Weitz, Jeffrey I., Angchaisuksiri, Pantep, Nielsen, Joern Dalsgaard, Kayani, Gloria, Farjat, Alfredo, Schellong, Sebastian, Bounameaux, Henri, Mantovani, Lorenzo G., Prandoni, Paolo, Kakkar, Ajay K.
Publicado 2020

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE

por Ageno, Walter, Farjat, Alfredo, Haas, Sylvia, Weitz, Jeffrey I., Goldhaber, Samuel Z., Turpie, Alexander G. G., Goto, Shinya, Angchaisuksiri, Pantep, Dalsgaard Nielsen, Joern, Kayani, Gloria, Schellong, Sebastian, Bounameaux, Henri, Mantovani, Lorenzo G., Prandoni, Paolo, Kakkar, Ajay K.
Publicado 2021

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry

por Apenteng, Patricia, Virdone, Saverio, Camm, John, Fox, Keith A A, Bassand, Jean-Pierre, Turpie, Alexander G G, Oh, Seil, Brodmann, Marianne, Cools, Frank, Barretto, Antonio C P, Nielsen, Jørn, Haas, Sylvia, Kayani, Gloria, Pieper, Karen S, Kakkar, Ajay K
Publicado 2023

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

por Atar, Dan, Berge, Eivind, Le Heuzey, Jean-Yves, Virdone, Saverio, Camm, A John, Steffel, Jan, Gibbs, Harry, Goldhaber, Samuel Z, Goto, Shinya, Kayani, Gloria, Misselwitz, Frank, Stepinska, Janina, Turpie, Alexander G G, Bassand, Jean-Pierre, Kakkar, Ajay K
Publicado 2020

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF

por Camm, Alan John, Steffel, Jan, Virdone, Saverio, Bassand, Jean-Pierre, Fox, Keith A A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Turpie, Alexander G G, Verheugt, Freek W A, Misselwitz, Frank, Herreros, Ramón Corbalán, Kayani, Gloria, Pieper, Karen S, Kakkar, Ajay K
Publicado 2023

Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE

por Cohen, Omri, Ageno, Walter, Farjat, Alfredo E., Turpie, Alexander G. G., Weitz, Jeffrey I., Haas, Sylvia, Goto, Shinya, Goldhaber, Samuel Z., Angchaisuksiri, Pantep, Gibbs, Harry, MacCallum, Peter, Kayani, Gloria, Schellong, Sebastian, Bounameaux, Henri, Mantovani, Lorenzo G., Prandoni, Paolo, Kakkar, Ajay K.
Publicado 2021